Chalkis Health Industry Co., Ltd (SHE:000972)
China · Delayed Price · Currency is CNY 3.410
+0.040 (1.19%)
Aug 4, 2026, 3:04 PM CST
Chalkis Health Industry Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,630 | 3,023 | 2,160 | 2,738 | 2,175 | 2,075 | |
Market Cap Growth | 5.90% | 40.00% | -21.13% | 25.89% | 4.83% | 17.47% |
Enterprise Value | 3,029 | 3,650 | 2,522 | 3,000 | 2,091 | 2,049 |
Last Close Price | 3.41 | 3.92 | 2.80 | 3.55 | 2.82 | 2.69 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 25.30 | 83.38 | - |
PS Ratio | 5.62 | 6.14 | 7.01 | 4.76 | 3.69 | 11.89 |
PB Ratio | 396.86 | 111.97 | -126.57 | 13.07 | 21.66 | 27.91 |
P/TBV Ratio | - | 313.10 | - | 14.58 | 23.28 | 30.86 |
P/FCF Ratio | 7.55 | 15.94 | - | - | 11.84 | - |
P/OCF Ratio | 6.44 | 12.26 | - | - | 11.00 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 6.47 | 7.42 | 8.19 | 5.21 | 3.55 | 11.75 |
EV/EBITDA Ratio | - | - | - | 28.50 | 21.18 | - |
EV/EBIT Ratio | - | - | - | 46.61 | 38.76 | - |
EV/FCF Ratio | 8.70 | 19.25 | - | - | 11.38 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 102.64 | 28.03 | -50.38 | 2.04 | 0.12 | 0.25 |
Debt / EBITDA Ratio | - | - | - | 4.05 | 0.12 | - |
Debt / FCF Ratio | 1.95 | 3.99 | - | - | 0.07 | - |
Net Debt / Equity Ratio | 60.12 | 16.45 | -41.00 | 1.51 | -1.94 | -0.03 |
Net Debt / EBITDA Ratio | -1.57 | -1.87 | -4.30 | 3.00 | -1.98 | 0.07 |
Net Debt / FCF Ratio | 1.14 | 2.34 | -5.25 | -0.79 | -1.06 | 0.01 |
Asset Turnover | 0.34 | 0.33 | 0.21 | 0.56 | 0.79 | 0.28 |
Inventory Turnover | 1.08 | 1.01 | 0.66 | 1.03 | 2.30 | 2.25 |
Quick Ratio | 0.34 | 0.36 | 0.14 | 0.16 | 0.51 | 0.39 |
Current Ratio | 0.72 | 0.76 | 0.81 | 0.85 | 0.90 | 0.77 |
Return on Equity (ROE) | - | -1127.41% | -242.11% | 70.45% | 29.85% | -83.64% |
Return on Assets (ROA) | -13.13% | -11.62% | -8.41% | 3.93% | 4.49% | -8.06% |
Return on Invested Capital (ROIC) | -66.63% | -84.52% | -56.52% | 29.84% | - | -68.65% |
Return on Capital Employed (ROCE) | -159.60% | -134.70% | -110.50% | 21.50% | 23.60% | -39.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -2.23% | -1.53% | -10.69% | 3.95% | 1.20% | -5.15% |
FCF Yield | 13.24% | 6.27% | -6.17% | -14.51% | 8.44% | -9.67% |
Payout Ratio | - | - | - | 15.21% | 49.50% | - |
Buyback Yield / Dilution | 0.16% | -0.07% | 0.02% | 11.27% | -13.96% | 2.44% |